Looking for COVID-19 tests for personal use?
Visit testnowandgo.com for at home testing kits
GENETWORx recognizes that patients want to know more about their genetics and health in order to live healthier, more productive lives. Our scientists and researchers work tirelessly to advance Molecular Diagnostic Testing to help healthcare professionals diagnose and treat a broad range of conditions more quickly, safely and accurately.
In LTC facilities, the prevalence of asymptomatic bacteriuria is higher than that of symptomatic UTI.
Treating asymptomatic LTC patients is associated with the following:
Collecting a clean catch urine sample is not always an option with senior living residents. It can be unpleasant for the resident and your staff. Sometimes, catch urine collection is not physically possible.
With GENETWORx as your UTI diagnostic laboratory, a swab of a wet, saturated brief is an alternative to a clean catch urine sample and provides a much easier collection process.
GENETWORx molecular pathogen testing identifies the specific pathogens that are causing the infection, as well as any antimicrobial resistance. The outcome is information that can help you select the optimal drug therapy for your patient.
GENETWORx offers a personalized, conveniet Phlebotomy program to provide patients accessibility to high quality, personal care.
Our mobile phlebotomists serve patients in long-term care facilities, offices and even within the comfort of patients’ own homes. Offer your patients quality care when you need it.
GENETWORx can detect more than 30 different types of pathogens and deliver 99% accurate results within 24-48 hours of lab sample receipt.
GENETWORx molecular pathogen testing is more accurate than standard culture testing. Our molecular pathogen testing detects anaerobic organisms growing deep inside that other tests may miss. 
Our rapid turnaround time is within 24-28 hours from laboratory receipt.
Our simple to read report gives clinicians quick, actionable intelligence to make better treatment decisions.
Ability to identify pathogens when the patient is on empiric antibiotic treatment.
With molecular testing, not only can you receive a clear picture of the type and percent of pathogens causing the infection, in many cases, you can identify antimicrobial resistance. With the power of molecular testing, you can select the optimal medication therapy for your patient, improve treatment outcomes and reduce healthcare spend.
GENETWORx’s Aura software, provided by Nucleus, provides patients and customers a total end to end digital management and medical data system which provides:
By continuing to browse or by clicking “Accept Cookies” you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.